Philippe Gonnard’s Post

According to the World Hypertension League (WHL), hypertension, or high blood pressure, is a major contributing factor to the global rise of non-communicable diseases (NCDs). It is considered the primary risk factor for death and disability worldwide. The WHL initiated #WorldHypertensionDay in 2005 with the objective of raising public awareness about this silent yet deadly condition, and to mobilize global efforts in combating hypertension. This year, the theme is a call to 'Measure Your Blood Pressure Accurately, Control It, Live Longer.’ #PSKAT60 #Hypertension #Pharmacology

Are you a healthcare professional involved in the screening, diagnosis and management of hypertension? Our brand-new Hypertension course is finally live. 🎉 Hypertension is often called the “silent killer”, serving as a key risk factor for strokes, ischaemic heart disease and renal disease.  Fortunately, it’s also one of the most preventable and treatable causes of premature death if identified and managed correctly. This is exactly why we wanted to create a course aimed specifically at building up your knowledge, confidence, and skills surrounding hypertension, its causes and its treatment.  Throughout this 7.5-hour course, you can expect to learn: ✅ The impact of hypertension on individual lives, wider society and other co-morbidities.  ✅ How to explain the normal mechanisms of blood pressure control.  ✅ How to confidently measure blood pressure, as well as how to detect hypertension.  ✅ The relevant risk factors that contribute to primary hypertension and the causes of secondary hypertension. ✅ The medications that can be used to manage hypertension. ✅ The key aspects of a hypertension annual review.  Ready to boost your knowledge and confidence in diagnosing and managing hypertension in your patients? Apply for our brand-new Hypertension course now: https://lnkd.in/esj4jEfi #Healthcare #AccreditedEducation #HealthcareSolutions #ShortCourse  

Managing a chronic, life-threatening disease like #HoFH is a difficult task. There are many treatment approaches, which are very expensive as most rare disease treatments, and in some countries they are not reimbursed or not available. Along with the medical treatment, life style modifications are required (in diet, exercise, work, activities etc.) in order to improve the daily routine and quality of life. Let's unite our voice with those suffering from HoFH to ask for accessible treatments! Persons with HoFH, apart from their medical treatment, need strength and perseverance. Our support and empathy can help them immensely to navigate through the challenges of living with such a demanding chronic disease. #Unite4HoFH #RareDiseases #KnowHoFH #FindHoFH #Maythe4thbewithyou

Managing #HoFH requires a life-long, multi-pronged #treatment approach beyond what is typically used for other forms of hypercholesterolemia. This may include a combination of statins, ezetimibe, PCSK9 inhibitors (for those with some LDLR residual activity), possibly LDL apheresis, a blood filtration procedure to remove LDL cholesterol, MTP inhibitors and ANGPTL3 inhibitors. Unfortunately, similar to many rare diseases, treatments for HoFH are often very expensive, not always reimbursed, or simply not available... and that holds for many people around the world. Without appropriate treatment, individuals with HoFH have a significantly reduced life expectancy compared to the general population due to the increased risk of cardiovascular events and complications from a young age. Treatment is more than just medication; it's evidence of the power of progress and perseverance. Let's complement treatment with empathy. Enter our logo contest to increase awareness for those managing HoFH. https://lnkd.in/eb7cy7Wi #Unite4HoFH #RareDisease, #UseHeart to #KnowHoFH and #FindHoFH #Maythe4thbewithyou

For three decades, I have been a steadfast companion to statins, those lipid-lowering medications prescribed with the aim of maintaining my cholesterol levels within a healthy range. This is further exacerbated by the spectrum of opinions out there on the internet regarding the utility of statins — from fervent endorsements to adamant declarations that they are an unnecessary expense. Friends in the latter camp assert that high cholesterol is not a true culprit in the saga of atherosclerosis. So, what does the science say. This article is my assessment to perhaps reassure myself and for my own peace of mind. It's also an acknowledgment that the landscape of atherosclerotic cardiovascular disease (ACVD) is nuanced and that the discussion surrounding statins will persist, branching into multifaceted arguments and counterargument. By sharing this article with you; I hope that you will come away with a deeper understanding of atherosclerosis and how it has multifaceted risk factors that are independent that needs to be managed. In Part 2 which I will be posting in the future; I will address some of the controversies that are out there in the internet and perhaps find some answers to them. #projectmanagment #construction #humanresources #malaysia #wellness

Getz Pharma facilitated the development of the National Hypertension Guidelines under the PREACH (PREvention, mAnagement, and Control of Hypertension) initiative to standardize hypertension management nationwide and shift the disease burden from tertiary to primary healthcare. These guidelines published in August 2023 serve as a source document for training healthcare professionals (HCPs) across Pakistan to effectively and comprehensively address hypertension, the silent killer. Read more here: https://lnkd.in/eNZiXFeM Get your blood pressure checked today for a timely diagnosis of hypertension. #GetzPharma #GhaurFarmaein #PREACH

Did you know that pulmonary hypertension (PH) is often misdiagnosed? At Johnson & Johnson, we are focused on our goals of shortening time from diagnosis to treatment and helping to ensure access to the right therapy at the right time. #JNJPulmonaryHypertension #PulmonaryHypertension

On May 17, 2024, JBIT College of Pharmacy observes World Hypertension Day. Hypertension, or high blood pressure, affects over one billion people globally and is a leading cause of cardiovascular disease and premature mortality. Two-thirds of instances of hypertension are found in low- and middle-income nations, where the burden of the disease is disproportionately felt. This is partly because these populations have experienced an increase in risk factors in recent decades. Furthermore, around half of those who have hypertension are ignorant of their illness, which increases their risk of needless medical problems and even death. Apply Now: www.jbitdoon.com #jbitgroupofinstitutions #Pharmacy #FutureStudents #AdmissionAlert #NewBeginnings #enrollment2024 #admissionseason2024 #nextchapter #StartYourJourney #sapnokodoudaan #uttarakhand #dehradun

High blood pressure affects millions worldwide and is a leading risk factor for cardiovascular disease. As healthcare providers, we have a critical role to play in hypertension management and prevention. This World Hypertension Day, we encourage all HCPs to visit the EMGuidance Platform for the latest evidence-based guidelines and treatment resources. Together, we can improve hypertension outcomes and support our patients in achieving optimal heart health. Read our latest article which discusses common antihypertensive medication classes, including diuretics, calcium channel blockers, ACE inhibitors, ARBs, and beta-blockers, outlining their mechanisms, clinical pearls, and appropriate monitoring. https://hubs.la/Q02xxhtb0 #WorldHypertensionDay #HypertensionManagement #HCPResources #EMGuidance

GLP-1s are popular, but are they the solution to our obesity problem? “What we know is that the efficacy and safety profile of these medications is substantially better than any weight loss drug in the past, while our obesity epidemic has only ballooned,” Ceci Connolly & Sami Inkinen said in their The Health Care Blog op-ed. Read it here: https://lnkd.in/e_Ny3NeN